Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 68.00
+0.97 (1.45%)
Jun 12, 2026, 3:29 PM IST
Valiant Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -32.68 | -22.01 | 3.2 | 289.98 | 340.74 |
Depreciation & Amortization | 60.4 | 20.93 | 19.66 | 15.63 | 24.26 |
Loss (Gain) From Sale of Assets | 0.31 | -0.05 | - | - | -0.59 |
Loss (Gain) From Sale of Investments | -0.29 | - | - | - | - |
Provision & Write-off of Bad Debts | 0.97 | 8.48 | - | - | - |
Other Operating Activities | 37.78 | 45.07 | -0.3 | 3.31 | -10.28 |
Change in Accounts Receivable | -214.43 | -272.42 | 428.41 | 222.01 | -791.1 |
Change in Inventory | -414.38 | 60.27 | 30.27 | 27.62 | 21.15 |
Change in Accounts Payable | 533.09 | 147.89 | -213.69 | 80.24 | 480.6 |
Change in Other Net Operating Assets | -75.09 | 24.99 | -248.69 | -78.28 | 72.9 |
Operating Cash Flow | -104.32 | 13.13 | 18.85 | 560.51 | 137.68 |
Operating Cash Flow Growth | - | -30.34% | -96.64% | 307.12% | - |
Capital Expenditures | -342 | -1,139 | -458.7 | -376.81 | -88.2 |
Sale of Property, Plant & Equipment | 0.28 | 0.56 | - | - | 0.59 |
Investment in Securities | 414.24 | 610.3 | -980.07 | -136.97 | - |
Other Investing Activities | - | - | - | -37.91 | -143.25 |
Investing Cash Flow | 72.52 | -527.68 | -1,439 | -551.68 | -230.85 |
Short-Term Debt Issued | - | 154.68 | 13.88 | - | - |
Long-Term Debt Issued | - | 296.86 | 152.63 | 3.72 | - |
Total Debt Issued | - | 451.54 | 166.5 | 3.72 | 19.21 |
Short-Term Debt Repaid | - | - | - | -12.81 | - |
Long-Term Debt Repaid | -762.56 | - | - | - | - |
Total Debt Repaid | -762.56 | - | - | -12.81 | -440.25 |
Net Debt Issued (Repaid) | -762.56 | 451.54 | 166.5 | -9.09 | -421.04 |
Issuance of Common Stock | 108.63 | - | 1,359 | - | 733.49 |
Other Financing Activities | 671.85 | -5.01 | -0.78 | -0.25 | -0.88 |
Financing Cash Flow | 17.92 | 446.53 | 1,524 | -9.34 | 311.57 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | 0 |
Net Cash Flow | -13.88 | -68.02 | 104.57 | -0.51 | 218.39 |
Free Cash Flow | -446.32 | -1,125 | -439.85 | 183.7 | 49.48 |
Free Cash Flow Growth | - | - | - | 271.26% | - |
Free Cash Flow Margin | -18.80% | -84.37% | -24.16% | 5.50% | 1.58% |
Free Cash Flow Per Share | -6.96 | -25.90 | -11.57 | 5.64 | 1.52 |
Cash Interest Paid | 17.84 | 1.75 | 0.78 | 0.25 | 0.36 |
Cash Income Tax Paid | 10.1 | -24.65 | -9.82 | 88 | 115.88 |
Levered Free Cash Flow | -484.86 | -1,355 | -400.31 | 290.4 | - |
Unlevered Free Cash Flow | -472.97 | -1,354 | -399.83 | 291.98 | - |
Change in Working Capital | -170.81 | -39.28 | -3.7 | 251.59 | -216.45 |